Unknown

Dataset Information

0

Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation in vitro and prevents vein graft neointimal formation ex vivo and in vivo.


ABSTRACT: Poor long-term patency of vein grafts remains an obstacle in coronary artery bypass grafting (CABG) surgery using an autologous saphenous vein graft. Recent studies have revealed that miR-126-3p promotes vascular integrity and angiogenesis. We aimed to identify the role of miR-126-3p in the setting of vein graft disease and investigate the value of miR-126-3p agomir as a future gene therapy in vein graft failure. Expression analysis of circulating miR-126-3p in plasma from CABG patients established the basic clues that miR-126-3p participates in CABG. The in vitro results indicated that elevated miR-126-3p expression significantly improved proliferation and migration in human saphenous vein endothelial cells (HSVECs) by targeting sprouty-related protein-1 (SPRED-1) and phosphatidylinositol-3-kinase regulatory subunit 2 (PIK3R2), but not in human saphenous vein smooth muscle cells (HSVSMCs). Moreover, the therapeutic potential of miR-126-3p agomir was demonstrated in cultured human saphenous vein (HSV) ex vivo. Finally, local delivery of miR-126-3p agomir was confirmed to enhance reendothelialization and attenuate neointimal formation in a rat vein arterialization model. In conclusion, we provide evidence that upregulation of miR-126-3p by agomir possesses potential clinical value in the prevention and treatment of autologous vein graft restenosis in CABG.

SUBMITTER: Qu Q 

PROVIDER: S-EPMC5739774 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation <i>in vitro</i> and prevents vein graft neointimal formation <i>ex vivo</i> and <i>in vivo</i>.

Qu Qingxi Q   Bing Weidong W   Meng Xiangbin X   Xi Jie J   Bai Xiao X   Liu Qing Q   Guo Yaqiu Y   Zhao Xin X   Bi Yanwen Y  

Oncotarget 20171103 63


Poor long-term patency of vein grafts remains an obstacle in coronary artery bypass grafting (CABG) surgery using an autologous saphenous vein graft. Recent studies have revealed that miR-126-3p promotes vascular integrity and angiogenesis. We aimed to identify the role of miR-126-3p in the setting of vein graft disease and investigate the value of miR-126-3p agomir as a future gene therapy in vein graft failure. Expression analysis of circulating miR-126-3p in plasma from CABG patients establis  ...[more]

Similar Datasets

| S-EPMC5660200 | biostudies-literature
| S-EPMC7492228 | biostudies-literature
| S-EPMC7184034 | biostudies-literature
| S-EPMC6560559 | biostudies-literature
| S-EPMC10586192 | biostudies-literature
| S-EPMC9841726 | biostudies-literature
| S-EPMC8299138 | biostudies-literature
| S-EPMC3148203 | biostudies-literature
| S-EPMC4548472 | biostudies-literature
| S-EPMC10902658 | biostudies-literature